The Gene Therapy and Cystic Fibrosis Centers Program currently supports three types of centers: Molecular Therapy Centers (P30), Cystic Fibrosis Research Centers (P30), and Specialized Centers for Cystic Fibrosis Research (P50). Molecular Therapy Centers provide shared resources to a group of investigators to facilitate development of molecular therapies for the treatment of cystic fibrosis and other genetic metabolic diseases. The Cystic Fibrosis Research Centers (P30) and Specialized Centers for Cystic Fibrosis Research (P50) provide resources and support research on many aspects of the pathogenesis and treatment of cystic fibrosis. These later two types of Centers will be replaced by the Cystic Fibrosis Research and Translation Core Center (P30) to support shared resources for both basic and clinical research on cystic fibrosis.
For further information, contact Dr. Catherine McKeon, Senior Advisor for Genetic Research.
